Administration of rmIL-31 further increased the expression levels of IL-4, IL-6, IL-10, and TGF-β1 in the skin and lungs of BLM-SSc mice, promoting the overexpression of Th2 and pro-fibrotic cytokines in these tissues. The gene discussed is IL6; the disease is systemic sclerosis.